✦ LIBER ✦

Sleep and depression assessment in patients with non-malignant chronic pain with extended release hydromorphone treatment

✍ Scribed by R. Calvo Falcón; I. Vazquez Naville; L. Perez Garcia; S. Hernandez Gonzalez; M. Perez Mendez; I. Cabrera Diaz; A. Sancho De Avila; J. Arranz Duran

Book ID: 116682171
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 35 KB
Volume: 13
Category: Article
ISSN: 1528-8447
DOI: 10.1016/j.jpain.2012.01.341

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PPN2 COGNITIVE FUNCTION IN CHRONIC NON-M

PPN2 COGNITIVE FUNCTION IN CHRONIC NON-MALIGNANT PAIN PATIENTS TREATED WITH EXTENDED-RELEASE MORPHINE SULFATE (AVINZA®)

✍ S Panjabi; R Panjabi; KA Lawson; MD Shepherd; JC Barner; M Johnsrud 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

878 PREVALENCE OF ANXIETY AND DEPRESSION

878 PREVALENCE OF ANXIETY AND DEPRESSION IN PATIENTS WITH CHRONIC NON-MALIGNANT PAIN

✍ X. Santiveri; M.D. Ferrer; A. Ruiz; R. Lopez; N. Pares; F. Escolano 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Opioids in non-cancer pain: Efficacy and

Opioids in non-cancer pain: Efficacy and safety of 24-hour hydromorphone hydrochloride extended-release compared with placebo in patients with nonmalignant pain

✍ E. Kopecky; C. Colonnese; M. Shi; C. Wright IV 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Dose Conversion and Titration with a Nov

Dose Conversion and Titration with a Novel, Once-Daily, OROS® Osmotic Technology, Extended-Release Hydromorphone Formulation in the Treatment of Chronic Malignant or Nonmalignant Pain

✍ Mark Palangio; Donald W Northfelt; Russell K Portenoy; Daniel Brookoff; Ralph T 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 395 KB

Comparative Efficacy of Oral Extended-Re

Comparative Efficacy of Oral Extended-Release Hydromorphone and Immediate-Release Hydromorphone in Patients with Persistent Moderate to Severe Pain: Two Randomized Controlled Trials

✍ Alan B. Grosset; Michael S. Roberts; Mark E. Woodson; Minggao Shi; Ruth E. Swant 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Sustained Safety and Efficacy of Once-Da

Sustained Safety and Efficacy of Once-Daily Hydromorphone Extended-Release (OROS® hydromorphone ER) Compared with Twice-Daily Oxycodone Controlled-Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer Pain

✍ Ute Richarz; Sandra Waechter; Rainer Sabatowski; Leszek Szczepanski; Heinrich Bi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB